胰腺癌的标志:聚焦TAM受体
Núria Vázquez-Bellón1, Neus Martínez-Bosch2, Pablo García de Frutos3
1Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB)-CSIC and Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain; PhD Program in Biomedicine, Facultat de Medicina (Campus Clínic), Universitat de Barcelona, Barcelona, Spain.
EBioMedicine
|August 13, 2024
概括
胰腺管道腺癌 (PDAC) 是一种具有侵略性的癌症. 本综述探讨了TAM受体如何影响PDAC特征,建议它们作为早期诊断和精确治疗目标的生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胰腺管道腺癌 (PDAC) 是一种具有很低生存率的高度侵袭性癌症.
- PDAC的特点是晚期诊断,复杂的遗传学,转移和治疗阻力.
- TAM (Tyro3,AXL,MerTK) 受体氨酸激酶与PDAC的发展和进展有关.
研究的目的:
- 审查TAM受体对PDAC特征的影响.
- 讨论TAM受体作为PDAC早期诊断生物标记物的潜力.
- 探索TAM受体作为新型PDAC精密疗法的点.
主要方法:
- 对TAM受体和PDAC研究的文献综述.
- 分析TAM信号在PDAC启动和进展中的作用.
- 综合证据,将TAM受体与PDAC特征联系起来.
主要成果:
- TAM受体显著影响PDAC特征,包括瘤微环境和治疗耐药性.
- 有证据表明,TAM受体表达与PDAC进展和预后不佳相关.
- 在PDAC启动,转移和免疫逃避中,TAM信号通路至关重要.
结论:
- 在PDAC的侵略性中,TAM受体起着至关重要的作用.
- 准TAM受体为PDAC精密疗法提供了一个有希望的策略.
- 对TAM受体的进一步研究可能会导致改善PDAC的早期诊断生物标志物.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


